Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Dec 19;1(1):8.
doi: 10.1186/1478-7547-1-8.

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

Raymond Hutubessy  1 , Dan Chisholm, Tessa Tan-Torres Edejer
Affiliations

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector

Raymond Hutubessy et al. Cost Eff Resour Alloc. .

Abstract

Cost-effectiveness analysis (CEA) is potentially an important aid to public health decision-making but, with some notable exceptions, its use and impact at the level of individual countries is limited. A number of potential reasons may account for this, among them technical shortcomings associated with the generation of current economic evidence, political expediency, social preferences and systemic barriers to implementation. As a form of sectoral CEA, Generalized CEA sets out to overcome a number of these barriers to the appropriate use of cost-effectiveness information at the regional and country level. Its application via WHO-CHOICE provides a new economic evidence base, as well as underlying methodological developments, concerning the cost-effectiveness of a range of health interventions for leading causes of, and risk factors for, disease.The estimated sub-regional costs and effects of different interventions provided by WHO-CHOICE can readily be tailored to the specific context of individual countries, for example by adjustment to the quantity and unit prices of intervention inputs (costs) or the coverage, efficacy and adherence rates of interventions (effectiveness). The potential usefulness of this information for health policy and planning is in assessing if current intervention strategies represent an efficient use of scarce resources, and which of the potential additional interventions that are not yet implemented, or not implemented fully, should be given priority on the grounds of cost-effectiveness.Health policy-makers and programme managers can use results from WHO-CHOICE as a valuable input into the planning and prioritization of services at national level, as well as a starting point for additional analyses of the trade-off between the efficiency of interventions in producing health and their impact on other key outcomes such as reducing inequalities and improving the health of the poor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Health System Goals.
Figure 2
Figure 2
Cost-effectiveness of selected interventions for epidemiological sub-region AfrD (total population: 294 million).
Figure 3
Figure 3
Maximum possible health gains from selected interventions to reduce the risks of cardiovascular disease, sub-region AmrA.
Figure 4
Figure 4
Steps towards the contextualisation of Generalized CEA in countries.
See this image and copyright information in PMC

References

    1. Hailey D. Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies. Soc Sci Med. 1997;45:563–581. doi: 10.1016/S0277-9536(96)00397-8. - DOI - PubMed
    1. Drummond M, Jonsson B, Rutten F. The role of economic evaluation in the pricing and reimbursement of medicines. Health Policy. 1997;40:199–215. doi: 10.1016/S0168-8510(97)00901-9. - DOI - PubMed
    1. Elsinga E, Rutten FF. Economic evaluation in support of national health policy: the case of The Netherlands. Soc Sci Med. 1997;45:605–620. doi: 10.1016/S0277-9536(96)00400-5. - DOI - PubMed
    1. Le Pen C. Pharmaceutical economy and the economic assessment of drugs in France. Soc Sci Med. 1997;45:635–643. doi: 10.1016/S0277-9536(96)00402-9. - DOI - PubMed
    1. Jamison DT, Mosley WH, Measham AR, Bobadilla JL. Disease control priorities in developing countries. New York, Oxford University Press. 1993.